The White House has published its Current Regulatory Plan and Unified Agenda of Regulatory and Deregulatory Actions reporting on regulatory priorities for spring 2014. The Agenda explains current good manufacturing practice requirements for outsourcing facilities that compound drugs and medication, which are expected to be formally proposed in November 2014.
view information here
view information here
No comments:
Post a Comment